New Study Shows Viagra Can Increase Life Expectancy In Men With Coronary Artery Disease

, , Leave a comment

A new study has found that men with stable coronary artery disease (CAD), who use viagra for impotency, are expected to live longer. These men as well are at a lower risk of suffering a new heart attack, said the experts. This study has been done by experts from the Karolinska Institutet in Sweden. The director of clinical cardiology at Long Island Jewish Forest Hills in New York, Dr. Michael Goyfman has said that CAD leads to blockages in the arteries, which supply blood to the heart. As the arteries narrow due to blockages, the blood supply in many parts of the heart gets restricted. Specifically, with exertion, patients might deal with symptoms. Sudden occlusion of the coronary artery results in the damage of the heart muscles, which is a heart attack. The American Heart Association (AHA) has said that impotence, which is known as erectile dysfunction (ED), might be an early sign of heart disease in otherwise healthy men. Alprostadil is a treatment for ED, which is given as infection locally into the penis or as a suppository. This drug opens blood vessels to stiffen the penis. Viagra or Cialis (tadalafil) is another treatment option in the class of medication called PDE5 inhibitors (PDE5i). These drugs increase blood flow. Dr. Michael J. Blaha. The director of clinical research at John Hopkins Ciccarone Center for the Prevention of Cardiovascular Diseases has said that many men avoid early symptoms of heart disease, however with signs of ED; it will be easy to find out men who are at a higher risk of heart disease. The findings of the new study have been released in the Journal of the American College of Cardiology (ACC).

In the study, experts have compared the effects of these ED drugs on men who have been dealing with stable coronary artery disease. Experts have said that all participants have suffered a heart attack, balloon dilation, or bypass surgery at least 6 months before starting their treatment for ED. The lead author of the research, Dr. Martin J. Holzmann has said that the risk of a new heart attack is at its highest peak in the first 6 months, and later the coronary artery disease (CAD) is stable. Experts have looked at 16500 men who have been on PDE5 inhibitors along with 2000 men who have been given alprostadil. They have taken the data from the patients and drug, and cause of death registries in Sweden. Scientists have seen that men who have been taking PDE5 inhibitors have lived long. They have been at a reduced risk of a new heart attack, balloon dilation, heart failure, and bypass surgery as compared to patients who have been treated with alprostadil. The study has found that the immunity has been dose reliant that means more frequent doses of PDE5 inhibitors have led to even lower risk. However, experts have said that it has been an observational study. They have been able to find only a correlation between PDE5 inhibitors including viagra and reduced mortality in men with CAD as compared to ED patients who have been given alprostadil.

The lead author of the study, DR. Martin J. Holzmann has said that a study, which has been published in 2017, has shown that men with a recent myocardial infarction (MI) who have been taking PDE5 inhibitors have lived a long life. He has said that there is just one study that has been done on people with diabetes has come up with similar findings. The authors of the study have said that a lower risk of heart attack might be due to the way PDE5 inhibitors cater to one specific risk factor for heart disease. PDE5i drugs lead to a drop in systemic blood pressure. Since high blood pressure is a risk factor for heart disease, patients who take these drugs might have lower and controlled blood pressure. However, experts have said that there is a need for a randomized controlled trial to validate the findings of the observational study. Until these findings are verified, the current medical guidelines will remain the same.

 

Leave a Reply